Multiple receptors for dopamine

Nature

Volumn 277, Issue 5692, 1979, Pages 93-96

  Kebabian, John W ^a   Calne, Donald B ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; APOMORPHINE; BUTACLAMOL; CYCLIC AMP; DIHYDROERGOCRYPTINE; DOPAMINE; DOPAMINE RECEPTOR; EPININE; FLUPENTIXOL; HALOPERIDOL; METOCLOPRAMIDE; MOLINDONE; SPIPERONE; SULPIRIDE;

ENDOCRINE SYSTEM; SHORT SURVEY; SURVEY; TETRALIN 6,7 DIOL;

ADENYLATE CYCLASE; ANIMAL; APOMORPHINE; CORPUS STRIATUM; CYCLIC AMP; ERGOT ALKALOIDS; LIGANDS; MEMBRANE PROTEINS; PROLACTIN; RECEPTORS, DOPAMINE; STRUCTURE-ACTIVITY RELATIONSHIP; SUBSTANTIA NIGRA;

EID: 0018378511     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/277093a0     Document Type: Review

References (83)

1. Cools, A. R. & Van Rossum, J. M. Psychopharmacologia 45, 243–254 (1976).
2. Trabucchi, M., Longoni, R., Fresia, P. & Spano, P. F. Life Sci. 17, 1551–1556 (1975).
3. Spano, P. F., Govoni, S. & Trabucchi, M. Adv. biochem. Psychopharmac. 19, 155–165 (1978).
4. Creese, I., Burt, D. R. & Snyder, S. H. Life Sci. 17, 993–1002 (1975).
5. Kebabian, J. W. & Greengard, P. Science 174, 1346–1349 (1971).
6. Kebabian, J. W., Petzold, G. L. & Greengard, P. Proc. natn. Acad. Sci. U.S.A. 69, 2145–2149 (1972).
7. Brown, J. H. & Makman, M. H. Proc. natn. Acad. Sci. U.S.A. 69, 539–543 (1972).
8. Iversen, L. L. Science 188, 1084–1089 (1975).
9. Osborne, N. N. Experientia 33, 917–919 (1977).
10. Harmar, A. J. & Horn, A. S. Molec. Pharmac. 13, 512 (1977).
11. Clement-Cormier, Y. C., Kebabian, J. W., Petzold, G. L. & Greengard, P. Proc. natn. Acad. Sci. U.S.A. 71, 1113–1117 (1974).
12. Miller, R., Horn, A., Iversen, L. & Pinder, R. Nature 250, 238–241 (1974).
13. Sheppard, H. & Burghardt, C. R. Molec. Pharmac. 1, 721–726 (1974).
14. Ginos, J. F., Cotzias, G. C., TQlosa, E., Tang, L. C. & LaMonte, A. J. med. Chem. 18
15. 1194–1200 (1975).
16. Kebabian, J. W. Adv. Cyclic Nucleotide Res. 8, 421–508 (1977).
17. Ernst, A. M. Acta physiol, pharmacol. neerl. 15, 141–154 (1969).
18. Brown, E. M., Carroll, R. J. & Aurbach, G. D. Proc. natn. Acad. Sci. U.S.A. 74, 4210–4213 (1977).
19. Miller, R. J., Horn, A. S. & Iversen, L. L. Molec. Pharmac. 10, 759–766 (1974).
20. Karobath, M. & Leitich, H. Proc. natn. Acad. Sci. U.S.A. 71, 2915–2918 (1974).
21. Lippmann, W., Pugsley, T. & Merker, J. Life Sci. 16, 213–224 (1975).
22. Miller, R. J., Horn, A. S. & Iversen, L. L. J. Pharm. Pharmac. 27, 212–213 (1975).
23. Beam, K. G. & Greengard, P. Cold Spring Harb. Symp. quant. Biol. 40, 157–168.
24. Libet, B., Kobayashi, H. & Tanaka, T. Nature 258, 155–157 (1975).
25. Mav, R. M. in Frontiers in Neuroendocrinology (eds Martini, L. & Gunong, W. F.) 4, 169–194 (Raven, New York, 1976).
26. Thorner, M. O. Clin. Endocrin. Metab. 6, 201–222 (1977).
27. Birge, C. A., Jacobs, L. S., Hammer, C. T. & Daughaday, W. H. Endocrinology 86, 120–130 (1970).
28. MacLeod, R. M., Fontham, E. H. & Lehmeyer, J. E. Neuroendocrinology 6, 283–294
29. (1970).
30. MacLeod, R. M. & Lehmeyer, J. E. Endocrinology 94, 1077–1085 (1974).
31. Smalstig, E. G., Sawyer, B. D. & Clemens, J. A. Endocrinology 95, 123–129 (1974).
32. Caron, M, G. et al. J. biol. Chem. 253, 2244–2253 (1978).
33. Calabro, M. A. & MacLeod, R. M. Neuroendocrinology 25, 32–46 (1978).
34. Creese, I., Schneider, R. & Snyder, S. H. Eur. J. Pharmac. 46, 377–381 (1977).
35. Gill, D. M. Adv. Cyclic Nucleotide Res. 8, 85–108 (1977).
36. Rappaport, R. S. & Grant, N. H. Nature 248, 73–75 (1974).
37. De Camilli, P., Spada, A., Giovannelli, M., Meldolesi, S. & Faglia, G. Abstracts 7th
38. International Congress of Pharmacology, 596 (IUPHAR, Paris, 1978).
39. Aghajanian, G. K. & Bunney, B. S. Naunyn-Schmiedebergs Archs Pharmac. 297, 1–7
40. (1977).
41. Carlson, A. in Pre- and Postsynaptic Receptors (eds Usdin, E. &. Bunney, W. E.) 49–65
42. (Marcel Dekkcr, New York, 1975).
43. Phillipson, O. T. & Horn, A. S. Nature 261, 418–20 (1976).
44. Kebabian, J. W. & Saavedra, J. M. Science 193, 683–685 (1976).
45. Krueger, B. K., Forn, J., Walters, J- R., Roth, R. H, & Greengard, P. Molec. Pharmac. 12, 639–648 (1976).
46. Hattori, T. & McGeer, E. G. Brain Res. 129, 174–180 (1977).
47. DiChiara, G., Porceddu, M. L., Spano, P. F. & Gessa, G. L. Brain Res. 130, 374–382 (1977).
48. Meltzer, H. Y., Goode, D. J, & Fang, V. S. in Psychopharmacology: A Generation of
49. Progress (eds Lipton, M. A., DiMascio, A. & Kill am, K. F.) 509–529 (Raven, New York, 1978).
50. Calaf, J. in Human Prolactin (eds Pasteels, I. L. & Robyn, C.) 220–225 (Excerpta Medica, Amsterdam, 1973).
51. Yamuchi, J., Takahara, J. & Ofuji, T. Life Sci. 20, 1581–1584 (1977).
52. Roufogalis, B. D., Thornton, M. & Wade, D N. Life Sci. 19, 927–934 (1976).
53. Bunney, B. S., Roth, R. H, & Aghajanian, G. K. Psychopharm. Commun. 1, 349–358
54. (1975).
55. Steinsland, O. S. & Hieble, J. P. Science 199, 443–445 (1978).
56. Iversen, L. L., Rogawski, M. A. & Miller, R. J. Molec. Phav. 12, 251–262 (1976).
57. Goldberg, L. I., Volkman, P. H. & Kohli, J. D. A. Rev. Pharmac. Toxic. 18, 57–79 (1978).
58. Schorderet, M. Neurosci. Leu. 2, 187–191 (1976).
59. Markstein, R., Herring, P. L., Burki, H. R., Asper, H. & Ruch, W. J. Neurochem. (in the press).
60. Trabucchi, M., Spano, P. F., Tonon, G. C. & Frattola, L. Life Sci. 19, 225–232 (1976).
61. Pieri, L., Keller, H. H., Burkard, W. & DaPrada, M. Nature 211, 278–280 (1978).
62. Schmidt, M. J. & Hill, L. E. Life Sci. 20, 789 (1977).
63. Kebabian, J. W., Caine, D. B. & Kebabian, P. R. Commun. Psychopharmac. 1, 311–318
64. (1977).
65. Seeman, P. Biochem. Pharmac. 26, 1741–1748 (1977).
66. Creese, I., Burt, D. R. & Snyder, S. H. Science 192, 481–483 (1976).
67. Burt, D. R., Creese, I. & Snyder, S. H. Molec. Pharmac. 12, 800–812 (1976).
68. Seeman, P., Lee, T., Chau-Wong, M., Tedesco, J. & Wong, K. Proc. natn. Acad. Sci. U.S.A. 73, 4354–4358 (1976).
69. Tittler, M., Weinreich, P. & Seeman, P. Proc. natn. Acad. Sci. U.S.A. 74, 3750–3753
70. Roberts, P. J., Woodruff, G. N. & Poat, J. A. Molec. Pharmac. 13, 541–547 (1977).
71. Schwarcz, R., Creese, I., Coyle, J. T. & Snyder, S. H. Nature 271, 766–768 (1978).
72. Hyttel, J. Life Sci. 23, 551–556 (1978).
73. Kebabian, J. W. Life Sci. 23, 479–84 (1978).
74. Kebabian, J. W. & Kebabian, P. R. Life Sci. (in the press).
75. Rolland, R. & Schellenkens, L. A. Acta endocr. 88, 119–130 (1978).
76. Thomer, M. O. & Besser, G. M. Acta endocr. 88, 131–146 (1978).
77. Andersch, B., Hahn, L., Wenderstam, C., Ohman, R. & Abrahamson, L. Acta endocr. 88, 165–174 (1978).
78. Besser, G., Wass, J. A. H. & Thorner, M. O. Acta endocr. 88, 187–198 (1978).
79. Caine, D. B. et al. Lancet i, 735–737 (1978).
80. Ayd, F. J. Dis. Nerv. Syst. 35, 447–52 (1974).
81. Pendleton, R. G., Samler, L., Kaiser, C. & Ridley, P. T. Eur. J. Pharmac. 51, 19–28 (1978).
82. Setler, P. E., Sarau, H. M., Zerkle, C. L. & Saunders, H. L. Eur. J. Pharmac. 50, 419–430
83. Peringcr, E., Jcnner, P., Donaldson, I. M., Marsden, C. D. & Miller, R. Neuropharmacology 15, 463–469.